Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|January 12, 2017
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancerAngelica L Quartino, Hanbin Li, Jin Y Jin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH studyC Jackisch, S-B Kim, V Semiglazov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistanceA M Yahanda, K M Alder, G A Fisher, et al.
Cancer|December 1, 1985
A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinomaF M Torti, L D Shortliffe, S K Carter, et al.
Leukemia|May 3, 2002
Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemiaN J Lacayo, B L Lum, D L Becton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistanceB L Lum, S Kaubisch, A M Yahanda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicitiesWells A Messersmith, Daniel A Laheru, Neil N Senzer, et al.
Blood|August 1, 1985
Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an updateJ E Sanders, E D Thomas, C D Buckner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imagingD I Rosenthal, P Nurenberg, C R Becerra, et al.
Investigational New Drugs|January 23, 2010
Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)Hai T Tran, Ralph G Zinner, George R Blumenschein, et al.
Pageof 17